| National Speech Language Therapy Center | |
|
412 1st St Se, Washington, DC 20003-1804 | |
| (202) 470-4185 | |
| (833) 803-2521 |
| Full Name | National Speech Language Therapy Center |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 412 1st St Se, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306488630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| National Speech Language Therapy Center 5606 Shields Dr, Bethesda, MD 20817-3571 Ph: () - | National Speech Language Therapy Center 412 1st St Se, Washington, DC 20003-1804 Ph: (202) 470-4185 |
News Archive
The U.S. District Court for the Southern District of Indiana today upheld Eli Lilly and Company's (NYSE: LLY) method-of-use patents on Evista(R) (raloxifene HCl tablets). In the case of Eli Lilly and Company v. Teva Pharmaceuticals Industries Ltd., the court ruled in favor of Lilly on all accounts for these method-of-use patents, including the patent doctrines of obviousness, enablement, and inequitable conduct.
New research at ACR Convergence, the American College of Rheumatology's annual meeting, reveals that people of color with rheumatic disease have worse health outcomes from COVID-19 infection, are more likely to be hospitalized to treat their coronavirus infection, and are more likely to require invasive ventilator treatment
Blocking the mineralocorticoid receptor (MR)- a protein that helps maintain normal levels of salt and water in the body- in immune cells may help reduce the risk of heart attack and stroke by improving blood vessel health.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today its results for the third quarter ended September 30, 2010.
› Verified 9 days ago
Sheryl Jacob Desbordes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-4424 | |
Karen Garrido-nag, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Speech, Language And Hearing Sciences, Washington, DC 20002 Phone: 202-448-6964 Fax: 202-448-5324 | |
Voicetrainer, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Pennsylvania Ave Nw, Suite 300, Washington, DC 20006 Phone: 202-580-6646 Fax: 202-580-6559 | |
Samantha Wasilus, M.S CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4880 Macarthur Blvd Nw, Washington, DC 20007 Phone: 202-333-1403 Fax: 202-333-1404 | |
Tahera Sparks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Connecticut Ave Nw # 100, Washington, DC 20008 Phone: 202-525-1641 | |
Sydney Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Massachusetts Ave Ne Ste C9, Washington, DC 20002 Phone: 202-544-5469 | |
Joyce Doyle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3009 5th St Se, Washington, DC 20032 Phone: 571-221-2840 |